A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
